About | Free Trial

Last Update


This profile was last updated on . .

Is this you? Claim your profile.

Background Information

Employment History

Senior Consultant Endocrinologist

Apollo Hospital

Senior Consultant, Department ofEndocrinology

Apollo Hospital

Senior Consultant Endocrinologist

Indraprastha Apollo Hospital

Senior Consultant

Apollo Centre for Obesity , Diabetes and Endocrinology

Senior Consultant Endocrinologist

Indaprastha Apollo Hospital

Apollo Hospital

Web References (15 Total References)

childhealthcongress's posterous - Filed under 'endcrinology'

childhealthcongress.posterous.com [cached]

Dr. S.K. Wangnoo

Sr. Consultant, Dept. ofEndocrinology,
Apollo Hospital, New Delhi

I have been prescribing rosiglitazone to ...

vv.telegraphindia.com [cached]

I have been prescribing rosiglitazone to a select group of patient in my clinical practice and have been following them regularly, and they are doing well and are yet to report any untoward cardiovascular effects,? said Dr. S. K. Wangnoo, Senior Consultant Endocrinologist, Apollo Hospital, New Delhi.

Preventive measures can help diabetics avoid brain stroke, heart attacks

www.bihartimes.com [cached]

"In India, five to 10 percent of the patients of diabetes suffer from brain stroke after the age of 60 years," said S.K. Wangnoo, senior consultant endocrinologist at the Indraprastha Apollo Hospital.

"Diabetes patients are having accelerated atherosclerosis (more cholesterol depositions in blood vessels) due to which patients are prone to develop brain stroke or heart attack two to four times more than non-diabetic patients," he added.

"Indians have the so-called 'thrifty ...

week.manoramaonline.com [cached]

"Indians have the so-called 'thrifty genotype'-our genes are tuned so as to take care of metabolic requirements in periods of limited food intake," says Dr S.K. Wangnoo, senior consultant at Apollo Centre for Obesity, Diabetes and Endocrinology in Delhi.

"An injectable molecule of the GLP-1 class, bydureon, is approved in Europe and awaiting approval in India," says Wangnoo.
"Three gliptins," says Wangnoo, "are approved for usage in India: sitagliptin, saxagliptin and vildagliptin. The newest gliptin, linagliptin, is awaiting approval in India. Saxaglyptin has proved effective in the treatment of type 2 diabetics with kidney problems (not end-stage renal disease). This molecule is marketed by Bristol-Myers Squibb as Onglyza. Studies presented at the EASD indicate that long-term treatment of type 2 diabetes with gliptins for two years appeared to maintain improvement in HbA1C levels, adds Wangnoo. "These are relatively safe, with low potential for hypoglycaemia," he says.
"The EndoBarrier is a liner that fits inside a section of the intestine," says Wangnoo.

EFFECTIVE youth Ministry

www.iasym.org [cached]

16 S.K. Wangnoo, senior consultant endocrinologist at Delhi's Indaprastha Apollo Hospital

Similar Profiles

Other People with this Name

Other people with the name Wangnoo

Vijay Wangnoo
Wang Hospitality Equipment Pvt. Ltd

Rohit Wangnoo
Amdocs Limited

Sunil Wangnoo
IBM Corporation

Abraham Wangnoo
UFCW 1189

S. Wangnoo
Endocrine Society of India

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory